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Investigating the role of the argonautes during mouse
embryogenesis
Sihem Cheloufi, Gregory Hannon
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A combination of genetic, biochemical and structural studies
has helped us dissect components of the RNA Induced
Silencing Complex (RISC) and how they orchestrate different
populations of small RNAs to regulate the genome. However,
very little is known about the biological role of the RISC
components. We have shown that Dicer and Argonaute2 are
essential during mouse embryogenesis. Dicer deficient mice die
around gastrulation and Ago2 deficient mice develop up to
midgestion with heart and neural tube malformations. In
mammals, the Argonautes are classified into two subfamilies:
a family that is germline specific and a family that is more
ubiquitously expressed. Ago2 belongs to the latter family and
has been very well characterized biochemically. It associates
with microRNAs and has been demonstrated to be the slicer
enzyme responsible for cleaving target messenger RNAs.
However, Ago2’s role in regulating gene expression at the
transcriptional and translational level is still unclear. We
propose that the catalytic function of Ago2 is essential for its
developmental role and we are testing this by generating a
catalytically dead Ago2 mouse. Even less is known about the
remaining family members, Argonaute1, Argonaute3 and
Argonaute 4. We have generated mice deficient in Ago1,
Ago2, Ago3 and Ago4 as well as Ago1/3 double and Ago1/3/4
triple knockout mice. So far, we have shown that the action of
Ago1, Ago3, Ago4 or Ago1/3 is not required for completion of
embryogenesis. Dissecting the argonautes genetic mutants
together with unraveling their biochemical function, will help
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Muscle diseases such as muscular dystrophies pose a
challenge to medicine and society since no cure has been
found to date. Recent studies suggested that head and trunk
muscles use different programs for their embryonic develop-
ment. However, the program for craniofacial muscle develop-
ment is not understood. Fgf8 is a regulator for skull and heart
development. As it is expressed next to the branchial arch
muscle, Fgf8 may control the patterning and differentiation of
head muscles. Grafting Fgf8-beads, it was found that MyoR, a
marker for undifferentiated and proliferating myoblasts was
upregulated. Conversely, markers for differentiating cells such
as Myf5 were downregulated. This suggests that Fgf8 may
stimulate head myoblast proliferation and inhibit their
differentiation. Genes indicative of muscle pattern were also
affected: En2, which labels the developing jaw muscles in the
mandibular arch, was upregulated, while Paraxis, a marker for
the lateral rectus eye muscle, was downregulated. This finding
suggests a role of Fgf8 in the promotion of branchiomeric and
the suppression of extraocular muscle development. We
showed that a signal from the neural tube positively regulates
extraocular muscle development and negatively regulates
branchiomeric muscles development. We propose a model
by which antagonising signals from the neural tube and
branchial arches pattern the craniofacial musculature. Fgf8
agonists and antagonists are expressed in the mesodermal core
of the arches, which suggest that Fgf8, expressed in the
endoderm, may signal directly to the mesoderm and thereby




Sox9 negatively regulates the expression of the muscle
specific gene alpha sarcoglycan during myogenesis in
C2C12 cells culture
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The sarcoglycan sarcospan complex is composed of the
transmembranal proteins a, b, g, d y e SG as well sarcospan.
Mutations in a, b, g, d SG cause autosomal recessive limb girdle
muscular dystrophies. a SG is expressed exclusively in striated
muscle. Due to this observations, a tissue specific a SG gene
expression regulation has been suggested. In this regard it has
been demonstrated that the a SG mRNA is positively regulated
during myogenesis, which implicate the myogenic factors
participation on the expression of this protein. Recently, our
group has demonstrated the interaction of MyoD with the
transcription factors TFIIB and TFIID in the a SG promoter
region. In order to know the mechanisms involved in the
negative regulation of this gene, we analyzed the sox9
participation. We analyzed the luciferase activity driven by a
SG promoter C2C12 cells cotransfected with cDNA of sox9, the
a SG promoter is down-regulated in 80% in C2C12 myoblasts,
but not in myotubes where the endogenous sox9 expression
level is undetectable. We analyzed the endogenous a SG mRNA
level in a C2C12 stable line that overexpresses Sox9. The
transcript was reduced in 60% with respect to wild type cells, as
well as the a SG protein. By immunofluorescence analysis we
find the colocalization of Sox9 and MyoD in myoblasts cell
nucleus and we are analyzing the possibility of p-Smad3
interacting with sox9 and MyoD, which suggests a myostatin
dependent mechanism of regulation. In this moment we are
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